Zai Lab ZLAB
$21.03 −$0.89 (-4.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.03 0.00%
Open$20.99
Prev close$21.92
Day range$20.02 – $21.15
Volume1.44M
Market cap$2.36B
P/E (TTM)–
Dividend yield–
ZLAB Stock News
Headlines matching Zai Lab or the ZLAB ticker, most recent first.
- J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36
- Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45 Positive
- US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10% Positive
- Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37
- U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% Sequentially Positive
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36 Positive
- Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44 Negative
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32 Negative
- Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47
- J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39
No comments yet — be the first to weigh in on ZLAB.
Sign in to join the discussion.